The odds of a Fed rate hike in September just soared after U.S. Federal Reserve Chair Janet Yellen said the argument for raising interest rates has strengthened.
Yellen made the comment Friday at the Fed’s symposium in Jackson Hole, Wyo. But she wasn’t the only Fed official who spoke. Vice Chair Stanley Fisher suggested the Fed might actually raise rates twice this year.....More>>>
Many people don’t realize it, but when you get that final paycheck, it is one of the most important financial events of your life. The idea of no longer working for money and having access to a paycheck can do weird things to some people. In many cases, it can turn them into a penny pinching, wheeling-dealing, cheapskate who will go out of their way to save a buck or get a better....More>>>
With legal marijuana sales in North America expected to climb from $6.7 billion in 2016 to over $20 billion by 2020, the prices of some marijuana penny stocks will skyrocket right along with the 198% increase in sales.
Marijuana penny stocks are still speculative investments, and only some will see their share prices jump thanks to the industry’s growth. But we want to make sure....More>>>
Pipeline giant Kinder Morgan (NYSE:KMI) has been on the upswing in recent days after reporting better than expected Q3 2016 results. The company was able to hit most of the marks analysts were looking for, lowering debt and leverage as well as providing a crucial update to its capital return (dividends) plans.
Issued by state and local governments, municipal bonds yield an average of just 2.5%. But you wont owe a penny in federal tax on most types of muni-bond income, and you can get a break on state taxes, too, if you invest in munis issued in the state where you reside. For instance, if you live in a state with a stiff income tax, such as California, and are in the top combined federal and state....More>>>
Almost all the coverage you will find about Sunshine Capital Inc is press releases by Sunshine Capital Inc. Sunshine trades over the counter and is currently priced at $6.00 per share making it, in the view of my stick in the mud investor adviser, a “penny stock” too volatile for his firm to get involved with. A recent press release from Sunshine obliges me to clarify a piece I....More>>>
In this series, we look through the most recent Dividend Channel ”DividendRank” report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider’s view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and....More>>>
Shares of Achaogen (AKAO) rose by up to 90% just a few months after my December article suggesting readers buy the secondary offering. The stock has completed the round trip back down and then some, currently in the red by 20% from where we first started.
Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that wo